Nov 21, 2024 | Bariatric surgery, GLP-1s, MedBen Rx, Wegovy, Weight loss, Weight loss drugs, Zepbound
Bariatric surgeries to treat obesity dropped 25.6% from 2022 to 2023, while prescriptions for GLP-1 drugs more than doubled during that period, according to a new study of privately insured Americans with obesity. However, those who opt for the surgery are seeing...
Jun 10, 2024 | Affordable Care Act, Caroline Fraker, MedBen Rx, Obesity, Wegovy, Weight loss, Weight loss drugs, Zepbound
While most health plans do not currently cover obesity medications like Wegovy and Zepbound – and MedBen Rx recommends clients continue not to do so – constant media coverage means the calls to do so will only grow. Therefore, employers are increasingly considering...
May 13, 2024 | Diabetes, Kurt Harden, MedBen Rx, MedBen University, Mounjaro, Ozempic, Wegovy, Weight loss, Zepbound
At recent MedBen University roundtables, MedBen President & CEO Kurt Harden examined how the growing public awareness of two diabetes drugs with a desirable side effect – significant weight loss – means that these $1,000-per-month medications are not always being...
Feb 5, 2024 | MedBen News, Online Services, Prescription, Telehealth, Weight loss, Zepbound
A major drug manufacturer is stepping up efforts to make its new weight-loss drug more accessible to potential users. Eli Lilly recently launched LillyDirect, a direct-to-consumer platform that connects obese patients to telehealth doctors who can prescribe the GLP-1...
Nov 14, 2023 | Drug costs, Obesity, Pharmacy, Prescription, Wegovy, Weight loss, Zepbound
In light of all the attention that weight loss drugs have received lately – as well as the pricing havoc these drugs have been causing in some pharmacy plans – the following news items have caught our attention: North Carolina says its health plan will...
